CYCLOPHARMA - IXO PE

You seem to have Javascript disabled. This website needs javascript in order to function properly!

Fonds IR APL	VL⁽¹⁾	Perf.⁽²⁾
FIP APL 2012	2,99 €	23.3%
FIP APL 2013	4,73 €	28.2%
FIP APL 2014	35,50 €	-25.5%
FIP APL 2015	22,03 €	-35.6%
FIP APL 2016	69,43 €	54.9%
FIP APL 2017	45,15 €	-34.3%
FIP APL 2018	77,28 €	-8.7%
FIP APL 2019	89,50 €	-10.5%
FIP APL 2020	96,03 €	-4%
FIP APL 2021	98,37 €	-1.6%
FIP APL 2022	101,14 €	1.1%
FIP APL 2023	100,00 €	0%

Fonds IR GSO	VL⁽¹⁾	Perf.⁽²⁾

Fonds ISF	VL⁽¹⁾	Perf.⁽²⁾
FCPI iXO DEVELOPPEMENT 4	18,48 €	-7.7%
FIP iXO DEVELOPPEMENT N6	19,16 €	66.9%
FIP iXO DEVELOPPEMENT N7	16,71 €	22.4%
FIP iXO DEVELOPPEMENT N8	24,27 €	0.1%
FIP iXO DEVELOPPEMENT N9	81,87 €	52.5%

Distributions effectuées	Par part	Perf.⁽²⁾
FIP APL 2012	120,29 €	23.3%
FIP APL 2013	123,42 €	28.2%
FIP APL 2014	39,00 €	-25.5%
FIP APL 2015	42,35 €	-35.6%
FIP APL 2016	85,45 €	54.9%
FIP APL 2017	20,53 €	-34.3%
FIP APL 2018	14,00 €	-8.7%
FIP APL 2019	0,00 €	-10.5%
FIP APL 2020	0,00 €	-4%
FIP APL 2021	0,00 €	-1.6%
FIP APL 2022	0,00 €	1.1%
FIP APL 2023	0,00 €	0%
FCPI iXO DEVELOPPEMENT 4	905,00 €	-7.7%
FIP iXO DEVELOPPEMENT N6	147,73 €	66.9%
FIP iXO DEVELOPPEMENT N7	105,71 €	22.4%
FIP iXO DEVELOPPEMENT N8	75,80 €	0.1%
FIP iXO DEVELOPPEMENT N9	70,60 €	52.5%

VL⁽¹⁾: Dernière Valeur Liquidative de la part
Perf.⁽²⁾: Performance du Fonds hors avantage fiscal
(*) : Fonds qui ont partiellement distribué
(L) : Fonds Liquidé

Back

Cyclopharma is a specialist in radiotracers for the medical imaging market.

Company sold in 2018

Investor(s):
Alexandre Sagon

Participation: majoritaire 

Activities:
Molecular imagery

Leaders:
Olivier Carli

IXO intervention: 2,7 M€

Sales figures: 22 M€ (2016)

Effective: n.d